Mount Sinai BioDesign expands collaboration with MedTech community to enhance medical innovation

Mount Sinai Health System today announced that Mount Sinai BioDesign, the medical technology incubator of the Health System, has expanded its reach to become a key, effective partner for the broader MedTech community.

GM-2505 by Gilgamesh Pharmaceuticals for Psychiatric Disorders: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 5, 2023

Backers of menthol cigarette ban vow to keep up the fight, but concede it will be a long battle

WASHINGTON — Advocates of a federal ban on menthol cigarettes have spent the better part of the last decade trying everything — from federal lawsuits

April 30, 2024

Severe Maternal Morbidity at First Birth Linked to Lower Subsequent Birth Rates

Women who experienced severe maternal morbidity with their first birth were less likely to have more children, a retrospective Swedish population-based cohort study suggested. Among

November 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.